<?xml version="1.0" ?>
<document id="0892e16c218542d3a099d7b10aec24cab4bfce55">
  <chunk id="0892e16c218542d3a099d7b10aec24cab4bfce55.c0" text="Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model">
    <entity charOffset="9-16" id="0892e16c218542d3a099d7b10aec24cab4bfce55.c0.e0" ontology_id="CHEBI_59132" text="antigen" type="chemical"/>
  </chunk>
  <chunk id="0892e16c218542d3a099d7b10aec24cab4bfce55.c1" text="have led to improved progression-free survival of many patients; however the therapies are toxic, rarely achieve durable long-term complete responses and are not curative."/>
  <chunk id="0892e16c218542d3a099d7b10aec24cab4bfce55.c2" text="the ccRCC milieu to combat T cell exhaustion is an innovation in this field that should provide renewed potential for CAR T cell immunotherapy of solid tumors where limited efficacy is currently seen."/>
</document>
